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wild-type and Pkd1−/− cells. This was characterized by 
phosphorylation and nuclear accumulation of p-SMAD2/3, 
as well as altered expression of downstream target genes 
and epithelial-to-mesenchymal transition markers. This 
response was still present after cilia ablation. An inhibi-
tor of upstream type-I-receptors, ALK4/ALK5/ALK7, as 
well as TGF-β-neutralizing antibodies effectively blocked 
SMAD2/3 activity. In contrast, an activin-ligand trap was 
ineffective, indicating that increased autocrine TGF-β 
signaling is involved. To study potential involvement of 
MAPK/ERK signaling, cells were treated with a MEK1/2 
inhibitor. Surprisingly, fluid flow-induced expression of 
most SMAD2/3 targets was further enhanced upon MEK 
inhibition. We conclude that fluid shear stress induces auto-
crine TGF-β/ALK5-induced target gene expression in renal 
epithelial cells, which is partially restrained by MEK1/2-
mediated signaling.
Keywords Fluid flow · Mechanotransduction · Cilia · 
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Abbreviations
ADPKD  Autosomal dominant polycystic kidney 
disease
ALK  Activin-like kinase
AS  Ammonium sulfate
Cdh1  Cadherin-1
Col1a1  Collagen, type I, alpha 1
COX2  Cyclo-oxygenase-2
DPBS  Dulbecco’s phosphate-buffered saline
ELISA  Enzyme-linked immunosorbent assay
EMT  Epithelial-to-mesenchymal transition
ERK  Extracellular signal-regulated kinase
Fn1  Fibronectin 1
Abstract Renal tubular epithelial cells are exposed to 
mechanical forces due to fluid flow shear stress within the 
lumen of the nephron. These cells respond by activation of 
mechano-sensors located at the plasma membrane or the 
primary cilium, having crucial roles in maintenance of cel-
lular homeostasis and signaling. In this paper, we applied 
fluid shear stress to study TGF-β signaling in renal epithe-
lial cells with and without expression of the Pkd1-gene, 
encoding a mechano-sensor mutated in polycystic kidney 
disease. TGF-β signaling modulates cell proliferation, dif-
ferentiation, apoptosis, and fibrotic deposition, cellular pro-
grams that are altered in renal cystic epithelia. SMAD2/3-
mediated signaling was activated by fluid flow, both in 
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Hprt  Hypoxanthine–guanine 
phosphoribosyltransferase
MAPK  Mitogen-activated protein kinase
MEK  MAPK/ERK kinase
qPCR  Quantitative polymerase chain reaction
PAGE  Polyacrylamide gel electrophoresis
Pai1  Plasminogen activator inhibitor 1
PC  Polycystin
Pkd1  Polycystic kidney disease 1
PTEC  Proximal tubular epithelial cell
Ptgs2  Prostaglandin G/H synthase 2
RIPA  Radioimmunoprecipitation assay
sActRIIB-Fc  Soluble activin receptor-IIB fusion protein
SDS  Sodium dodecyl sulfate
SMAD  Mothers against decapentaplegic homolog
TBS  Tris-buffered saline
TGF-β  Transforming growth factorβ
TGF-β Ab  TGF-β neutralizing antibody
Vim  Vimentin
Introduction
Cellular mechano-sensitivity plays fundamental roles in 
cell viability and function, tissue development, and main-
tenance of organs [1]. For example, the kidney has the 
capacity to increase glomerular filtration rate in response 
to physiological stimuli. In addition, in renal diseases, 
hyperfiltration usually occurs in the remaining func-
tional nephrons to compensate for the lost glomeruli and 
nephrons [2]. Fundamental in the regulation of altered fluid 
shear stress are primary cilia and other mechano-sensors, 
and defects in cilia formation and function have profound 
effects on the development of body pattern and the physiol-
ogy of multiple organ systems [3]. The signaling modules 
responsible for the flow-sensing response involve a number 
of proteins located in the cell membrane, cilium and/or at 
the ciliary base, including polycystin-1 (PC-1) and the ion 
channel polycystin-2 (PC-2), encoded by the genes mutated 
in patients with autosomal dominant polycystic kidney 
disease (ADPKD) [4, 5]. At the plasma membrane and in 
cilia, polycystins interact with diverse (mechanosensory) 
ion channels, signal transducers as well as cell–cell and 
cell–extracellular matrix junctional proteins [6–11]. There-
fore, the polycystins are thought to play a role in differen-
tiation and maintenance of the cell structure, mechanical 
force transmission, and mechanotransduction [1, 12, 13]. 
Lack of the polycystin complex in cilia is one of the pro-
posed mechanisms of renal cyst formation [14, 15]. Moreo-
ver, mutations or deletions of other ciliary proteins can also 
cause renal cystic disease in mouse models and patients, 
indicating the role of cilia during cystogenesis [16, 17]. In 
the absence of polycystins, renal epithelial cells lack the 
capability to respond to signals needed to maintain the epi-
thelium differentiated, finally resulting in cyst formation 
[15].
Primary cilia also play essential roles as signal transduc-
ers in growth factor signaling. Ligands in the tubular fluid 
flow bind to their receptors, inducing cellular responses 
through downstream signaling pathways, for instance 
affecting the hedgehog (Hh), epidermal growth factor 
receptor (EGFR), Wnt and transforming growth factor β 
(TGF-β) pathways [3, 18]. Although not exclusively, recep-
tors involved in these pathways have been identified in the 
cilium of several cell types, including renal epithelial cells, 
suggesting that different signaling cascades are being reg-
ulated by this organelle [3, 18–20]. The above-mentioned 
data indicate that primary cilia are essential in organizing 
different signaling systems that sense environmental cues 
and transmit signals to the cell interior. Gene expression 
and the overall cellular behavior will be the effect of an 
integration of the different signaling pathways, triggered by 
flow and by growth factor or cytokine stimulation.
A cytokine previously reported to be involved in fluid 
flow and shear stress-regulated signaling is TGF-β [21, 
22]. The TGF-β superfamily members are multifunctional 
cytokines and include among others TGF-βs, activins, 
and bone morphogenetic proteins (BMPs). TGF-β signal-
ing modulates cell proliferation, differentiation, apoptosis, 
adhesion, and cell migration, and is believed to play a cru-
cial role in fibrotic deposition [23], which is seen in cyst 
formation [24]. TGF-β, as well as activin and Nodal, binds 
to a pair of serine/threonine kinase transmembrane recep-
tors that mediate the phosphorylation of receptor-regulated 
SMAD2 and 3. These phosphorylated SMAD proteins, 
p-SMAD2 and -3, form a complex with SMAD4 and can 
enter the nucleus where they act as transcription factors to 
regulate the transcription of various genes.
In embryonic endothelial cells, shear stress-mediated 
TGF-β/activin receptor-like kinase 5 (ALK5) signaling 
induced endothelial-to-mesenchymal transition, depend-
ing on the strength of shear and presence or absence of a 
cilia [21, 25]. A similar type of observation was made for 
renal epithelial cells, where fluid shear stress dynamically 
regulated TGF-β gene expression and SMAD3 activa-
tion, depending on the magnitude of fluid shear, i.e. physi-
ological versus pathological, and depending on NOTCH4 
expression [22, 26]. Increased SMAD2/3 activation and 
increased TGF-β signaling has been shown in several ani-
mal models for renal cystic disease and patient-derived tis-
sues [24, 27].
Given the role for SMAD2/3 signaling in shear stress but 
also in cyst formation, we aim to characterize in this study 
the cellular response of renal epithelial cells to fluid shear 
stress by unraveling the signaling cascades, particularly 
focusing on SMAD2/3 signaling and the effect of MAPK/
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ERK signaling. Our data indicate that both SMAD2/3 and 
epithelial-to-mesenchymal transition (EMT) processes 
are altered upon fluid flow stimulation in proximal tubu-
lar epithelial cells (PTEC) with and without Pkd1-gene 
expression, as shown by phosphorylation of SMAD2/3 
and nuclear translocation of p-SMAD2/3 and Snail. This 
leads to altered expression of target genes and EMT mark-
ers, shown in ciliated and non-ciliated cells. These pro-
cesses are regulated by an interplay between SMAD2/3 
and ERK1/2 signaling, and can be partially modulated by 
upstream ALK4/5/7 and MEK1/2 inhibitors and TGF-β 
neutralizing antibodies, while the soluble activin recep-
tor-IIB fusion protein (sActRIIB-Fc) was ineffective. We 
conclude that the fluid shear stress response in PTECs is 




SMAD2 (L16D3; #3103) and Snail (C15D3; #3879) anti-
bodies were from Cell Signaling Technology. Acetylated 
α-tubulin (clone 6-11B-1; #T6793) antibody and Phalloi-
din-Atto 594 (#51927) were from Sigma-Aldrich. Anti-
body against α-tubulin (DM1A; #CP06) was from Calbio-
chem, Merck Millipore. Antibodies against p-SMAD2 and 
p-SMAD3 have been described previously [28, 29]. Goat 
anti-Rabbit IgG (H + L) Alexa Fluor 488 conjugate (#A-
11008), Goat anti-Mouse IgG (H + L) Alexa Fluor 488 
conjugate (#A-11029), and Goat anti-Mouse IgG (H + L) 
Alexa Fluor 594 conjugate (A-11032) were from Life Tech-
nologies. Goat-anti-Rabbit IRDye 800CW (#926-32211) 
and Goat-anti-Mouse IRDye 680 (#926-32220) were from 
LI-COR Biosciences.
Chemicals
ALK4/5/7 inhibitor LY-364947 (10  µM; Calbiochem; 
#616451) was from Merck Millipore and SB431542 
(10  µM; #1614) was from Tocris Bioscience. TGF-β-
neutralizing antibody (clone 2G7) was a gift from Dr. E. 
de Heer (Pathology, LUMC, Leiden); sActRIIB-Fc was a 
gift from Prof. Olli Ritvos (Haartman Institute, Helsinki, 
Finland). MEK1/2 inhibitor Trametinib (GSK1120212; 
#S2673) was from Selleckchem. Recombinant human TGF-
β1 (#100-21) and recombinant human TGF-β2 (#100-35B) 
were purchased from PeproTech. Recombinant human/
mouse/rat activin A (#338-AC) and recombinant human 
activin B (#659-AB) were from R&D systems.
Cell culture
SV40 large T antigen-immortalized murine proximal tubu-
lar epithelial cells (PTEC) (Pkd1wt and Pkd1−/−), derived 
from a Pkd1lox,lox mouse, were generated and cultured as 
described previously [30]. Cells were maintained at 37 °C 
and 5%  CO2 in DMEM/F-12 with GlutaMAX (Gibco, 
Life Technologies; #31331-093) supplemented with 
100  U/ml Penicillin–Streptomycin (Gibco, Life Technolo-
gies; #15140-122), 2% Ultroser G (Pall Corporation, Pall 
BioSepra, Cergy St Christophe, France; #15950-017), 1× 
Insulin–Transferrin–Selenium–Ethanolamine (Gibco, 
Life Technologies; #51500-056), 25  ng/l Prostaglandin 
E1 (Sigma–Aldrich; #P7527), and 30  ng/l Hydrocorti-
sone (Sigma–Aldrich; #H0135). Cell culture was monthly 
tested without mycoplasma contamination using Myco-
Alert Mycoplasma Detection Kit (Lonza; LT07-318). New 
ampules were started after 15 passages.
For growth factor stimulation or fluid flow experi-
ments, cells were cultured on collagen-I (Advanced Bio-
Matrix; #5005) coated culture dishes or glass slides. Prior 
to treatment, cells were serum-starved to exclude effects of 
serum-derived growth-factors and to synchronize cells and 
cilia formation. For growth factor stimulation, 100% con-
fluent cells were serum-starved overnight and incubated 
with the specified ligands in the absence of medium sup-
plements. Stimulation was done with 5  ng/ml TGF-β1 or 
TGF-β2 or 100 ng/ml activin A or activin B, unless differ-
ently specified. For fluid flow stimulation, cells grown until 
high confluency underwent 24  h serum starvation before 
the start of the treatment. Cilia formation was checked on a 
parallel slide by immunofluorescence using anti-acetylated 
α-tubulin antibodies (Sigma Aldrich; #T6793). ALK4/5/7 
inhibitor (10  µM), MEK1/2 inhibitor (10  µM) or DMSO 
control (0.1%) were added 1  h before start of ligand or 
flow stimulation in the absence of medium supplements. 
To sequester TGF-β or activin ligands, TGF-β neutralizing 
antibodies (10 µg/ml) or sActRIIB-Fc (5 µg/ml) was added 
at the start of treatment, by replacing serum-free medium.
Fluid flow stimulation
Cells were exposed to laminar fluid flow (0.25–2.0  dyn/
cm2) in a cone–plate device or parallel plate flow cham-
ber. The cone–plate device, adapted from Malek et al. [31, 
32], was designed for 3.5  cm cell culture dishes (Greiner 
Bio-One). Cells were grown on collagen-I-coated dishes 
until confluence, followed by 24 h serum starvation, before 
dishes were placed in the cone–plate flow system and incu-
bated at 37 °C and 5%  CO2. The confluent cell monolayer 
of 9.6  cm2 was subjected to fluid shear stress using 2  ml 
serum-free DMEM/F-12 medium with viscosity (μ) of 
0.0078  dyn s/cm2 [33]. Constant laminar (Re = 0.3) fluid 
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flow was induced using a cone angle (α) of 2° and a veloc-
ity (ω) of 80 rpm, generating a fluid shear stress (τ = μω/α) 
of 1.9 dyn/cm2.
The parallel plate flow chamber was previously 
described [34, 35]. Briefly, cells were grown on collagen-
I-coated glass slides of 36 × 76  mm (Fisher Scientific 
#15178219) until confluence, followed by 24  h serum 
starvation, before glass slides were placed in a flow cham-
ber. A confluent cell monolayer of 14.2 cm2 (24 × 59 mm) 
was subjected to fluid shear stress using 7.5 ml serum-free 
DMEM/F-12 medium. Fluid was pumped at a constant flow 
rate (Q) of 5.5 ml/min through the chamber with 300 µm 
height (h), generating a constant laminar (Re = 5.0) fluid 
shear stress (τ = 6μQ/h2b) of 2.0 dyn/cm2, unless differently 
specified. The parallel plate flow chamber was placed in an 
incubator at 37 °C and 5%  CO2.
Static control cells were incubated for the same time 
in equal amounts of serum-free DMEM/F12 medium at 
37 °C and 5%  CO2. After 4 until 20 h fluid flow or control 
(static) stimulation, medium was collected and cells have 
been harvested for mRNA isolation and/or protein isolation 
for gene expression analysis or western blot. Ammonium 
sulfate (AS) was used to remove primary cilia as previ-
ously described [36]. Cells were pre-treated with 50  mM 
ammonium sulfate, followed by 6 h fluid flow in serum-free 
medium or 16 h fluid flow in medium containing 25 mM 
AS, to prevent cilia restoration. Control cells were treated 
similarly, but without AS.
Reporter assay
PTECs were cultured in 3.5  cm culture dishes and trans-
fected after 24 h with 4 µg SMAD3-SMAD4 transcriptional 
reporter  (CAGA12-Luc) [37] and 200 ng renilla luciferase 
reporter as a transfection control (pGL4.75[hRlucCMV]; 
Promega; #E6931) using 10 µl Lipofectamine 2000 accord-
ing to the manufacturer’s protocol (Life Technologies; 
#11668019). Cells were maintained under serum-free con-
ditions from the moment of transfection and fluid flow was 
started 24 h after transfection. Cells were lysed after 20 h 
of fluid flow stimulation using a cone–plate device. Firefly 
and renilla luciferase activities were measured on a lumi-
nometer (Victor 3; PerkinElmer) using the Dual-Luciferase 
Reporter Assay System (#E1960) from Promega according 
to the manufacturer’s instructions. Firefly luminescence 
was corrected for renilla to get the relative activity of the 
reporter.
Gene expression analysis
Total RNA was isolated from cultured cells using TRI 
Reagent (Sigma–Aldrich; #T9424) according to manufac-
turer’s protocol. Gene expression analysis was performed 
by quantitative PCR (qPCR) as described previously [38]. 
Briefly, cDNA synthesis was done using Transcriptor 
First Strand cDNA Synthesis Kit (Roche Applied Science; 
#04897030001) according to the manufacturer’s protocol. 
Quantitative PCR was done in triplicate on the LightCy-
cler 480 II (Roche) using 2× FastStart SYBR-Green Master 
(Roche; #04913914001) according to the manufacturer’s 
protocol. Data was analyzed with LightCycler 480 Soft-
ware, Version 1.5 (Roche). Gene expression was calculated 
using the  2− ΔΔCt method as described previously [39] and 
normalized to the housekeeping gene Hprt, giving the rela-
tive gene expression. Mean gene expression and standard 
deviation of the different treatment groups were calcu-
lated. For primer sequences see Supplementary Material 1, 
Table S1.
ELISA
Total and endogenously active levels of TGF-β1, TGF-β2, 
and TGF-β3 in medium collected after fluid flow experi-
ments were determined by ELISA as previously described 
[40, 41] using ELISA Duosets of TGF-β1 (DY1679), TGF-
β2 (DY302), and TGF-β3 (DY243) from R&D systems.
Western blot analysis
Cells were either scraped in DPBS and 1:1 diluted in 2× 
RIPA buffer or directly lysed in 1× RIPA buffer (50 mM 
Tris–HCl, pH 7.4, 150  mM NaCl, 1  mM EDTA, 1% Na-
DOC, 1% NP-40). Throughout the lysis procedure, 50 mM 
NaF, 1  mM  Na2VO4, and 1× complete protease inhibitor 
cocktail (Roche; #05892970001) were used to inhibit phos-
phatase and protease activity. Cell lysate was homogenized 
by three 5 s pulses of sonification followed by 30 min gen-
tle shaking at 4 °C. Insoluble cell debris was removed by 
15  min centrifugation at 14,000×g. Protein concentration 
was determined using Pierce BCA protein assay kit (Ther-
moFisher Scientific; #23227).
Western blot was performed on total protein cell 
extracts using p-SMAD2, SMAD2, p-SMAD3 or tubu-
lin antibodies. Cell lysates (10–20 µl) were separated on a 
10% SDS–PAGE gel. Proteins were transferred to 0.2 µm 
nitrocellulose membranes (Bio-Rad; #1704158) using 
Trans-Blot Turbo Transfer System (Bio-Rad; #1704155) 
at 1.3  A and 25  V for 10  min. Membranes were blocked 
for 1  h at room temperature in 25% SEA block blocking 
buffer (ThermoFisher Scientific; #37527) in TBS and incu-
bated overnight at 4 °C with antibodies against p-SMAD2 
(1:1000), SMAD2 (1:1000) or p-SMAD3 (1:1000) in 5% 
bovine serum albumin (BSA) in Tris-buffered saline con-
taining 0.1% Tween-20 (TBST). Tubulin or GAPDH were 
used as loading controls, with 1  h antibody incubation 
at room temperature. Goat-anti-Rabbit IRDye 800CW 
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(1:10,000) was used as secondary antibody for the detec-
tion of p-SMAD2. Goat-anti-Mouse IRDye 680 (1:12,000) 
was used as secondary antibody for the detection of total 
SMAD2 and Tubulin. Horseradish peroxidase conjugated 
secondary antibody (GE Healthcare, Waukesha, WI, USA) 
was used for the detection of p-SMAD3 or GAPDH using 
chemoluminescence according to the manufacturer’s pro-
tocol (Pierce, Rockford, IL, USA) as described previously 
[29]. Detection and densitometric analysis were carried out 
using the Odyssey Infrared Imaging System (LI-COR-Bio-
sciences). Protein levels were quantified using p-SMAD2/
SMAD2-integrated intensity ratios. Tubulin or GAPDH 
were used as a loading control.
Immunofluorescence
Cells were fixed in 4% paraformaldehyde and permeabi-
lized in 0.2% Triton-X100 in PBS for 15 min at room tem-
perature. Cells were blocked in 5% non-fat-dried milk in 
PBS for 1 h. Immunostaining for p-SMAD2 (1:1000) and 
Snail (1:1000) was performed overnight at 4 °C in 2% BSA 
in PBS followed by 1 h incubation with Goat anti-Rabbit 
IgG (H + L), Alexa Fluor 488 conjugate (1:2000) as sec-
ondary antibody. The cilium was stained with the antibody 
specific for acetylated-α-tubulin (1:2000) and Goat anti-
Mouse IgG (H + L) Alexa Fluor 594 conjugate (1:3000) or 
Alexa Fluor 488 conjugate (1:3000) as secondary antibody. 
F-actin was visualized using Phalloidin-Atto 594 (1:1500). 
Immunofluorescence slides were mounted with Vectashield 
containing DAPI after secondary antibody incubation and 
pictures were taken on the Leica DM5500 B microscope.
Statistical analysis
Results are expressed as mean ± SD. Differences between 
one treatment group and their controls were tested using 
two-tailed Student’s t tests. One- or two-way analysis of 
variance (ANOVA) was used, when three or more groups 
were compared, followed by post hoc Fisher’s LSD multi-
ple comparison, if the overall ANOVA F test was signifi-
cant. P < 0.05 was considered to be statistically significant.
Results
Fluid shear stress increases SMAD2/3 activity 
and alters expression of epithelial-to-mesenchymal 
transition (EMT) markers
To study fluid flow-induced cellular alterations, ciliated 
proximal tubular epithelial cells (PTEC; Fig.  1a) were 
exposed to a fluid shear stress of ~1.9  dyn/cm2, using a 
cone–plate device. After 6 or 16 h fluid flow exposure, gene 
expression was analyzed using quantitative PCR (qPCR). 
We first confirmed increased mRNA levels of Ptgs2, the 
gene encoding cyclo-oxygenase 2 (COX2), a known flow 
responsive gene (Fig. 1b) [42].
A crucial step in TGF-β signaling is the activa-
tion and translocation of phosphorylated SMAD2 and 3 
(p-SMAD2/3) to the nucleus to induce the expression of 
SMAD3 target genes, i.e., Pai1, Fn1, and Col1a1. Indeed, 
expression of these genes was significantly increased upon 
fluid flow at both time points indicating activation of this 
pathway (Fig.  1b). Increased TGF-β signaling was con-
firmed using the SMAD3-SMAD4 transcriptional reporter 
 CAGA12-Luc (Fig.  1c) [37]. In addition, elevated levels 
of p-SMAD2 and p-SMAD3 were detected by western 
blot analysis (Fig.  1d). Furthermore, nuclear transloca-
tion of p-SMAD2 was observed by immunofluorescence 
microscopy (Fig.  1e). Similar responses were seen in 
Pkd1−/− PTECs, in which expression of the Pkd1-gene, 
encoding a potential flow sensor [12], is disrupted (Sup-
plementary Material 1, Fig. S1). While expression of the 
SMAD2/3 targets was clearly elevated upon fluid flow, 
expression of the canonical and non-canonical Wnt tar-
gets (Ccnd1, Axin2, Birc5 (Survivin), Lin7a, Ppard, Glis2, 
Insc), and hedgehog targets (Gli1, Gli2, Gli3) was virtually 
not altered (Supplementary Material 1, Fig. S2).
Increased SMAD2/3 activity often is associated with 
dedifferentiation and EMT-like processes, regulated via 
the transcription factors Snail and/or Slug [43]. Indeed, 
we also observed differential expression of EMT marker 
genes Snai1, Snai2, Cdh1, and Vim, encoding the pro-
teins Snail, Slug, E-cadherin, and vimentin, respectively 
(Fig.  1f). mRNA levels of Snai1 and Vim were increased 
while expression of the epithelial marker Cdh1 was 
decreased. Even more, nuclear accumulation of Snail was 
detected upon fluid flow (Fig. 1g). Similar flow responses 
were seen in Pkd1−/− PTECs (Supplementary Material 
1, Fig. S1). Interestingly, while Snail and Slug frequently 
show co-expression [44], our data clearly show fluid flow-
induced downregulation of Snai2, the gene encoding the 
protein Slug. These data suggest that in this context Snail is 
responsible for the expression of mesenchymal markers and 
for repression of the epithelial E-cadherin gene.
TGF-β/activin-induced dose- and time-dependent 
activation of SMAD2/3 signaling
Next, we wondered whether TGF-β or activin, the 
cytokines that can induce SMAD2/3 phosphorylation, 
could generate the same gene expression pattern as fluid 
flow. Indeed, the same expression profile was observed 
upon TGF-β1 stimulation, including upregulation of Snai1 
and down-regulation of Snai2 (Fig.  2a). A dose response 
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curve and comparison of the cytokines indicated that the 
cells were more sensitive to TGF-β1 or -β2 as to activin A 
or B (Fig. 2b, c).
A time course experiment showed that expression of the 
canonical SMAD2/3 target, Pai1, was already significantly 
induced after 30  min of TGF-β1 stimulation (Fig.  2d), 
while Col1a1 followed at 60  min and Fn1 at 180  min. 
Surprisingly, Ptgs2 and Snai1 expression were also induced 
after 30 min (Fig. 2d) suggesting that these genes could be 
SMAD2/3 targets as well, because SMAD2 is phospho-
rylated within 30  min after TGF-β stimulation (Fig.  2e). 
The downregulated genes, Snai2 and Cdh1, showed a sig-
nificant decrease in expression starting at 60 and 180 min, 
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Fig. 1  Activation of SMAD2/3 signaling by fluid flow in ciliated 
PTECs. a Serum starvation induces cilia formation in proximal 
tubular epithelial cells (PTECs). Cilia are visualized using anti-acet-
ylated α-tubulin antibodies (red) and nuclei are stained with DAPI 
(blue). b Relative expression of Ptgs2 (COX2) and Pai1 (plasmi-
nogen activator inhibitor 1; Serpine1), Fn1 (EDA region; fibronec-
tin) and Col1a1 (collagen, type I, alpha 1) is increased upon fluid 
flow, as measured by quantitative PCR. Cone–plate induced fluid 
flow at t = 6 or 16  h; Hprt served as housekeeping gene to correct 
for cDNA input; data normalized to unstimulated PTECs at 6  h; 
n = 5 per condition; *P < 0.05 using two-way ANOVA. c SMAD3-
SMAD4  (GACA12-Luciferase) transcriptional reporter activity was 
elevated, as measured upon 20 h of fluid flow stimulation. Data nor-
malized to unstimulated PTECs (fold change); n = 4 per condition; 
*P < 0.05 using a two-tailed Student’s t test. d Western blot analysis 
of p-SMAD2 and p-SMAD3 shows increased phosphorylation upon 
6 and 16 h fluid flow stimulation. GAPDH served as loading control. 
e Nuclear accumulation of p-SMAD2 (green; t = 6 h, IF). Nuclei are 
visualized with DAPI (blue). f Relative expression of Snai1 (Snail) 
and Vim (vimentin) is increased, while relative expression of Snai2 
(Slug) and Cdh1 (E-cadherin) is reduced in PTECs stimulated with 
fluid flow, as measured by quantitative PCR. Cone–plate induced 
fluid flow at t = 6 or 16 h; Hprt served as housekeeping gene to cor-
rect for cDNA input; data normalized to unstimulated PTECs at 6 h; 
n = 5 per condition; *P < 0.05 using two-way ANOVA.  g Nuclear 
accumulation of Snail (green; t = 6 h, IF). Nuclei are visualized with 
DAPI (blue)
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Col1a1 are early responsive genes upon TGF-β stimulation, 
while Fn1 is a late responsive gene.
Altered expression of TGF-β/activin ligands 
and receptors upon fluid flow
Activation of SMAD2/3 is largely regulated via TGF-β or 
activin receptor complexes, upon binding of their respec-
tive ligands [23]. Therefore, expression of the genes coding 
for ligands TGF-β1, -2, and -3 or coding for activin A and 
B (i.e., Inhba and Inhbb) was measured by qPCR. Our data 
show a significant flow-induced increase in expression of 
Tgfb1 and Tgfb3 as well as Inhba and Inhbb upon 16 h fluid 
flow stimulation, while this trend was already visible upon 
6 h fluid flow (Fig. 3a). At both time-points Tgfb2 transcript 
levels were significantly decreased.
Next, we measured protein levels of TGF-β ligands in 
the medium collected after 16 h fluid shear (Fig. 3c). Total 
TGF-β1 and TGF-β2 levels were significantly decreased 
upon fluid flow in the medium, while active TGF-β1 was 
Fig. 2  Dose- and time-dependent activation of SMAD2/3 signaling 
by TGF-β and activin. a Increased expression of Pai1, Fn1, Col1a1, 
Ptgs2, Snai1, and Vim, and reduced expression of Snai2 and Cdh1, 
upon stimulation with 5  ng/ml TGF-β1 (n = 3, t = 4  h). b A dose 
response experiment shows increased sensitivity of Pai1 mRNA 
expression for TGF-β1 (n = 4) compared to activin B (n = 2) stimula-
tion (t = 4 h). c Pai1 expression shows stronger induction upon TGF-
β1 or TGF-β2, compared to activin A or activin B (n = 4 per condi-
tion, t = 4 h). d Time response (0–240 min) of target genes upon 5 ng/
ml TGF-β1 stimulation (n = 2). Expression was significantly different 
(P < 0.05; one-way ANOVA) with 5 ng/ml TGF-β1 stimulation com-
pared to non-treated controls for Pai1, Ptgs2, and Snai1 at 30  min; 
for Col1a1 and Snai2 at 60  min; for Fn1 and Cdh1 at 180  min. e 
Representative western blot of p-SMAD2 and SMAD2 upon 5 ng/ml 
TGF-β1 stimulation (time response of 0–240 min). Tubulin served as 
loading control. For quantification, p-SMAD2 levels were corrected 
for total SMAD2 and tubulin levels (n = 4). Relative mRNA expres-
sion was measured by quantitative PCR, where Hprt served as house-
keeping gene to correct for cDNA input (a–d). *P < 0.05 compared to 
non-treated control using a two-tailed Student’s t test. NS not stimu-
lated control
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lower, but not significantly changed by flow. TGF-β levels 
at 16  h fluid shear stress were significantly higher com-
pared to 6  h (Fig.  3c), suggesting there is production of 
latent TGF-β protein in time. Active and total TGF-β3 as 
well as active TGF-β2 were below detection levels (data 
not shown). In cell lysates, total TGF-β levels were mainly 
below detection level, except TGF-β1 levels of a few of the 
measured fluid flow samples at 16 h (data not shown).
We also analyzed expression of the different receptors. 
The type-I receptor ALK4 or ALK5 is recruited and trans-
phosphorylated by their specific type-II receptor upon bind-
ing of activin or TGF-β ligands, respectively. Expression of 
Alk5 (Tgfbr1) transcript was significantly increased upon 
fluid flow, while Alk4 (Acvr1b) was decreased (Fig.  3b). 
Expression of the type-II receptors did not change and Alk7 
(Acvr1c) was not expressed in PTECs (data not shown). 
Similar shear stress responses were seen in Pkd1−/− PTEC 
cells (Supplementary Material 1, Fig. S3). Overall, our data 
are inconclusive about the role of the ligands and receptors 
during fluid flow-induced SMAD2/3 activation. Neverthe-
less, increased SMAD2/3 activation could be the result of 
receptor activation.
Shear stress-induced SMAD2/3 target gene expression 
is flow-rate dependent, but partially cilia independent
We subsequently performed experiments using a paral-
lel plate flow chamber [34, 35] and confirmed the fluid 
shear-induced expression of SMAD2/3 target genes and 
EMT markers. With this device, fluid shear stress-induced 
SMAD2/3 target gene expression is lower compared to the 
cone–plate flow system and for several genes only the 16 h 
responses are significant (Fig. 4a). Likely, this can be attrib-
uted to the larger volume of culture medium that is circu-
lated in the parallel plate flow system, thereby diluting the 
concentration of ligands produced by the cells. A flow rate 
response curve showed a gradual increase of SMAD2/3 tar-
get gene expression (Fig. 4b). Surprisingly, removal of cilia 
by ammonium sulfate (AS) further enhanced the fluid flow-
induced expression of Pai1 and Ptgs2 (Fig. 4c–e), though 
Fn1 induction was lower. Our data suggest that cilia do not 
fully control the SMAD2/3 response in PTECs, indicating a 
complex fluid shear stress response, where yet unidentified 
mechano-sensors might be involved.
Shear stress-induced SMAD2/3 activation can be 
largely blocked by ALK4/5/7 inhibitors
To interfere with receptor activation, an ALK5 inhibi-
tor (LY-364947) that abrogates ALK4, ALK5, and ALK7 
kinase activity [45–48] was added to the medium. Cells 
were pre-incubated with the inhibitor and stimulated by 
fluid flow for 16  h using the parallel plate flow chamber. 
Expression of the SMAD2/3 target genes (Pai1, Fn1, 
and Col1a1), but also Ptgs2 was strongly reduced by the 
inhibitor in samples with and without flow, as shown for 
LY-364947 (Fig. 5a). However, expression was not entirely 
blocked and a very mild flow response can still be appreci-
ated, which is only significant for Ptgs2. These effects were 
confirmed using another ALK4/5/7 inhibitor, SB431542, 
Fig. 3  Fluid flow altered expression of the TGF-β and activin ligands 
as well as their receptors Alk5 and Alk4. a Relative expression of 
Tgfb1, Tgfb2, Tgfb3, Inhba, Inhbb and b Tgfbr1 (Alk5) and Acvr1b 
(Alk4) mRNA in PTECs upon fluid flow. Cone–plate-induced fluid 
flow at t = 6 or 16  h; qPCR, Hprt served as housekeeping gene to 
correct for cDNA input; data normalized to unstimulated PTECs at 
6 h; n = 5 per condition; *P < 0.05 using two-way ANOVA, followed 
by post hoc Fisher’s LSD multiple comparison. c Levels of TGF-β1 
(total and active) and TGF-β2 (total) in the medium of PTECs col-
lected after 6 or 16 h fluid flow. TGF-β3 and active TGF-β2 levels in 
medium and TGF-β1, 2, and 3 levels in cell lysates were below the 
detection limit. Cone–plate-induced fluid shear stress; TGF-β levels 
measured by ELISA; n = 5 per condition; *P < 0.05 using two-way 
ANOVA, followed by post hoc Fisher’s LSD multiple comparison
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which resulted in a similar pattern (data not shown). TGF-
β1-induced expression of SMAD2/3 targets (Pai1, Fn1, and 
Ptgs2) was similarly blocked by the ALK4/5/7 inhibitor 
(Supplementary Material 1, Fig. S4a).
Interestingly, the increased expression of Snai1 
(encoding Snail) was also strongly reduced with the 
ALK4/5/7 inhibitor, while the expression of Snai2 
(encoding Slug) was less reduced (Fig.  5a). Expression 
of the Snail target Cdh1 is increased with the ALK4/5/7 
inhibitor, but not altered by fluid flow, probably caused 
by the low induction of Snai1. These data suggest that, 
Fig. 4  Shear stress-induced SMAD2/3 target gene expression in 
PTECs is flow rate dependent, but partially cilia independent. a, b 
Relative expression (fold change) of Pai1, Fn1, Ptgs2, and Snai1 is 
gradually increased in time (a t = 4, 6 or 16  h; n = 5 per condition) 
and upon increasing flow rates in PTECs (b 0.25, 1.0 or 2.0 dyn/cm2; 
n = 3 per condition), as measured by quantitative PCR. Parallel plate 
flow chamber induced fluid shear stress; Hprt served as housekeeping 
gene to correct for cDNA input; data were normalized to static con-
trols (fold change). #Significant difference compared to unstimulated 
control (dashed line) or *significant difference between treatment 
groups (P < 0.05 by two-way ANOVA, followed by post hoc Fisher’s 
LSD multiple comparison). c To remove cilia, cells were treated with 
50 mM ammonium sulfate (AS) for 4 h, followed by 16 h post incu-
bation. Cilia were visualized by IF using anti-acetylated α-tubulin 
antibodies (green), F-actin using phalloidin antibodies (red) and 
nuclei were stained with DAPI (blue). Control cells clearly showed 
cilia staining, while AS-treated cells only showed weak or stunted 
cilia staining (arrowhead). d, e Relative expression of Pai1, Fn1, and 
Ptgs2 is increased upon 6 (d) or 16 (e) h fluid shear stress in controls 
and cells treated with 50 mM ammonium sulfate (AS), as measured 
by quantitative PCR. Parallel plate flow chamber induced fluid shear 
stress at 2.0 dyn/cm2 in PTECs; n = 5 per condition; Hprt served as 
housekeeping gene to correct for cDNA input; data were normalized 
to static controls (fold change). *P < 0.05 by two-way ANOVA, fol-
lowed by post hoc Fisher’s LSD multiple comparison. #Significantly 
altered expression by flow versus no flow (P < 0.05) using a two-
tailed Student’s t test
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besides Pai1, Fn1, Col1a1, and Ptgs2, also expression of 
Snai1 is largely mediated via SMAD2/3 signaling.
Shear stress-induced SMAD2/3 activation is abrogated 
by TGF-β neutralizing antibodies, but not by an activin 
ligand trap
To discriminate between ALK5 and ALK4 activation and 
to prevent ligand binding, TGF-β neutralizing antibodies 
(TGF-β Ab) or soluble activin receptor-IIB fusion proteins 
(sActRIIB-Fc) that functions as ligand trap for activin have 
been added to the medium of fluid flow-stimulated cells 
and controls [49–51]. Fluid shear stress-induced expres-
sion of SMAD3 target genes, Pai1 and Fn1, was signifi-
cantly decreased with TGF-β Ab, but not with sActRIIB-Fc 
(Fig. 5b, c). In control samples, i.e., static cells stimulated 
with exogenous TGF-β or activin, the responses were 
blocked, proving the efficacy of the inhibitors (Fig. 5e, Sup-
plementary Material 1, Fig. S4c, d). Also, the combination 
of TGF-β Ab and sActRIIB-Fc showed a similar decrease 
Fig. 5  ALK4/5/7 inhibitor and TGF-β neutralizing antibodies, but 
not sActRIIB-Fc, effectively block SMAD2/3 signaling upon fluid 
flow stimulation. a ALK4/5/7 inhibitor (LY-364947; n = 3) signifi-
cantly reduces baseline and fluid flow increased expression of Pai1, 
Fn1, Col1a1, Ptgs2, and Snai1 while the expression of Snai2 is 
less decreased. b TGF-β neutralizing antibodies (TGF-β Ab; n = 3) 
inhibited fluid flow-induced expression of SMAD2/3 target genes 
(Pai1 and Fn1), while c soluble activin type-IIB-receptor fusion 
protein (sActRIIB-Fc; n = 5) did not. d Combining TGF-β Ab with 
sActRIIB-Fc (n = 4) did not further increase the inhibitory effect. e 
TGF-β1 (n = 2) or activin B (n = 3) ligand-induced Pai1 expression 
was effectively inhibited by TGF-β Ab or sActRIIB-Fc, respectively 
(t = 4  h). Parallel plate flow chamber induced fluid shear stress in 
PTECs at t = 16  h (a–d); qPCR, Hprt served as housekeeping gene 
to correct for cDNA input; data normalized to unstimulated controls 
(fold change); n = 2–5 per condition as indicated. *P < 0.05 by two-
way ANOVA, followed by post hoc Fisher’s LSD multiple compari-
son. ALK inh ALK4/5/7 inhibitor (LY-364947), Combi trap combined 
ligand traps (TGF-β Ab and sActRIIB-Fc)
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in fluid shear-induced expression of SMAD3 target genes 
as TGF-β neutralizing Ab alone (Fig.  5d). From this, we 
conclude that shear stress-induced SMAD2/3 activity was 
strongly reduced by the ALK4/5/7 receptor kinase inhibitor 
and by TGF-β neutralizing Ab, but was not affected by the 
ligand trap sActRIIB-Fc, indicating a major role for TGF-β 
in the fluid shear stress response.
SMAD2/3 regulated gene expression is modulated 
by MEK1/2
In addition to activation of SMAD2/3 signaling, TGF-β 
receptors can also activate MAPK/ERK signaling, which 
is able to modulate SMAD2/3 transcriptional activity [52, 
53]. To interfere with MAPK/ERK signaling, an inhibitor 
was used that abolished MEK1/2 kinase activity, thereby 
preventing ERK1/2 phosphorylation [54]. Indeed, a 
MEK1/2 inhibitor (2 or 10 µM Trametinib, GSK1120212) 
reduced TGF-β1-induced expression of the canonical 
SMAD3 targets genes (Pai1, Fn1, and Col1a1) as well as 
Ptgs2 (Fig. 6a, Supplementary Material 1, Fig. S4b). Fur-
thermore, expression of Snai1 and Vim was reduced and, 
correspondingly, expression of the epithelial marker Cdh1 
was less decreased (Fig. 6a). Surprisingly, fluid flow induc-
tion of Pai1, Col1a1, Ptgs2, Snai1, and Vim was further 
enhanced with the MEK1/2 inhibitor, while the baseline 
and fluid flow-induced Fn1 expression was lower during 
MEK inhibition (Fig.  6b, Supplementary Material 1, Fig. 
S5a). This cannot be explained by a low TGF-β dose that is 
produced by PTECs during fluid flow, because SMAD2/3 
target gene expression was also reduced by the MEK1/2 
inhibitor during low dose (0.25–2 ng/ml) TGF-β1 stimula-
tion (Supplementary Material 1, Fig. S5b). This suggests a 
complex regulation of SMAD2/3 target genes during shear 
stress, which is differently modulated by MEK1/2 than in 
static cells upon exogenous TGF-β stimulation.
Discussion
Fluid flow stimulation has been used to study mechani-
cal shear stress in endothelial cells and osteoblasts for 
many years [55, 56]. In the last decade, this was extended 
to epithelial cells [57]. Even more, several inherited renal 
diseases are a consequence of dysfunctional primary cilia, 
with Polycystic Kidney Disease (PKD) as most promi-
nent example [15]. In PKD, a gradual decline of func-
tional nephrons results in compensatory hyperfiltration and 
increased shear stress in the remaining nephrons. In con-
trast, in a nephron that becomes cystic, tubular dilation will 
result in reduced fluid flow.
Our results show fluid flow induced TGF-β/ALK5-medi-
ated signaling, SMAD2/3 phosphorylation, and target gene 
expression in PTECs. This can be inhibited by an ALK4/5/7 
inhibitor, which indicates that, like in endothelial cells [21], 
autocrine signaling is involved. Even more, TGF-β neu-
tralizing antibodies block the flow response, similar to the 
inhibition of exogenously added active TGF-β1 under static 
conditions. In contrast, sActRIIB-Fc, a ligand trap that 
sequesters activin did not block the flow response, while 
the effect of exogenously added activin under static condi-
tions was completely blocked. A previous study reported 
that fluid shear stress dynamically regulated TGF-β gene 
expression and SMAD3 activation, depending on the mag-
nitude of fluid shear [22, 26]. In the current study, we con-
firmed in ciliated cells that the flow-induced response was 
depending on the magnitude of shear (0.25–2 dyn/cm2). In 
addition, cells were grown on a collagen type-I extracel-
lular matrix, which is known to influence the mechanical 
forces that are sensed by cells [58]. Upon deciliation of 
renal epithelial cells by ammonium sulfate [36], however, 
the fluid flow response remained (Fig.  4c–e). Moreover, 
expression of early responsive genes was enhanced upon 
deciliation, suggesting that to a certain extent primary cilia 
restrain TGF-β/ALK5 signaling. However, expression of 
the late-responsive gene Fn1 was less increased, indicat-
ing a complex regulation of the shear-induced SMAD2/3 
response in PTECs. These data also suggest involvement of 
yet unidentified mechano-sensors located at other parts of 
the plasma membrane.
The flow response could be inhibited by the ALK4/5/7 
inhibitor and TGF-β neutralizing antibodies, and TGF-β1 
and -3 mRNA levels were increased by fluid flow. However, 
latent TGF-β protein levels were lower in culture medium 
of shear stress-treated PTECs. It is conceivable that under 
flow conditions TGF-β processing and binding of the active 
ligand is enhanced, and therefore local effects are stronger. 
For example, growth factor shedding and autocrine sign-
aling via the intercellular space upon mechanical stimula-
tion of epithelial cells, had previously been shown for HB-
EGF [59]. However, this explanation is less likely, since 
latent TGF-β is excreted fast after production [60] and we 
showed accumulation in the medium (Fig. 3c, Supplemen-
tary Material 1, Fig. S3c). An alternative explanation could 
be associated to enhanced sensitivity for TGF-β, since we 
observed increased mRNA expression of the ALK5 recep-
tor upon fluid flow. In addition, increased flow-induced api-
cal endocytosis might play a role, as recently published for 
PTECs [61].
Also Pkd1−/− PTECs showed increased SMAD2/3 acti-
vation upon fluid flow treatment, suggesting that polycys-
tin-1, the protein encoded by Pkd1, is not directly involved 
in this response. Nevertheless, the response is slightly but 
significantly stronger in Pkd1−/− PTECs (Supplementary 
Material 1, Fig. S1k). Higher responsiveness in Pkd1 defi-
cient vascular smooth muscle cells and murine embryonic 
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fibroblast cells by TGF-β acting stimuli have been reported 
previously [62]. Alternatively, higher levels of TGF-β2, 
measured in the medium of Pkd1−/− PTECs during fluid 
flow (Supplementary Material 1, Fig. S3), might be respon-
sible for the enhanced response, which seems more likely 
given the fact that exogenous TGF-β1 or activin B stimu-
lation of static cells did not induce an enhanced response 
in Pkd1−/− PTECs (data not shown). In ADPKD kid-
neys, somatic inactivation of PKD1 or PKD2 is a critical 
step in cyst formation [63, 64]. ADPKD is a progressive 
disease in which the number and size of cysts increase in 
time accompanied by increased fibrosis. Consequently, the 
landscape of cells with and without polycystin expression, 
and nephrons with increased, reduced or no-flow condi-
tions alters in time as well. This is related to hyperfiltration, 
tubular dilation or tubular obstruction. Increased fluid shear 
stress and TGF-β signaling will occur in the nephrons com-
pensating the functional loss. So, the elevated response of 
Fig. 6  MEK inhibition modulates fluid shear-induced and TGF-β-
stimulated expression of SMAD2/3 target genes. a MEK inhibition 
(Trametinib, GSK1120212) reduces TGF-β1 increased expression of 
Pai1, Fn1, Col1a1, Ptgs2, Snai1, and Vim, while expression of Cdh1 
is less decreased. Snai2 expression was not significantly changed 
upon MEK inhibition. Relative mRNA expression measured at 
t = 4 h; n = 3; Hprt served as housekeeping gene to correct for cDNA 
input; data normalized to unstimulated controls. Significant differ-
ence (P < 0.05) by one-way ANOVA: acompared to 0  ng/ml TGF-
β1, bcompared to 0 ng/ml TGF-β1 + 10 µM MEK-inh, ccompared to 
5 ng/ml TGF-β1, dcompared to 5 ng/ml TGF-β1 + 2 µM MEK-inh or 
ecompared to 5 ng/ml TGF-β1 + 10 µM MEK-inh. b MEK inhibition 
(10 µM Trametinib) reduces fluid flow-increased expression of Fn1, 
while fluid flow increased expression of Pai1, Col1a1, Ptgs2, Snai1, 
and Vim is further elevated. Parallel plate flow chamber induced fluid 
shear stress in PTECs at t = 16 h; qPCR, Hprt served as housekeep-
ing gene to correct for cDNA input; data normalized to unstimulated 
controls (fold change); n = 3 per condition. *P < 0.05 by two-way 
ANOVA, followed by post hoc Fisher’s LSD multiple comparison. 
#Significantly altered expression by flow versus no flow (P < 0.05) 
using a two-tailed Student’s t test. MEK-inh MEK1/2 inhibitor (2 or 
10 µM Trametinib, GSK1120212)
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Pkd1−/− cells upon fluid flow is most relevant in the early 
phase upon disruption of the gene and during hyperfiltra-
tion in the remaining nephrons. Of course, when nephrons 
are dilated and the fluid flow itself is altered, the flow 
response will change again and probably diminish.
In ADPKD nuclear accumulation of SMAD2/3 in 
cystic epithelial cells and in interstitial fibroblasts, as well 
as elevated expression of target genes, points to a role of 
SMAD2/3-regulated signaling in epithelial dedifferentia-
tion and fibrosis [24, 27, 65]. In cystic epithelial cells of 
end-stage PKD, TGF-β1, and SMAD2/3 signaling was 
upregulated and associated with renal EMT and renal 
fibrosis [66]. Paradoxically, genetic disruption of the 
ALK5 receptor in renal epithelial cells did not affect cyst 
formation/growth and only slightly reduced expression of 
SMAD2/3 target genes, while the activin ligand trap, sAc-
tRIIB-Fc, significantly slowed down PKD progression in 
mice [65]. This indicates that for cyst formation and PKD 
progression, the tissue context and the different cell types 
involved are critical.
Increased SMAD2/3 activity is often associated with 
dedifferentiation and EMT-like processes, which is needed 
for epithelial cell plasticity and homeostasis during tissue 
development, maintenance, and repair [67]. TGF-β can 
induce Snail expression, which is known to directly repress 
epithelial markers like E-cadherin [68], and TGF-β can 
induce expression of markers of the mesenchymal pheno-
type, including vimentin [69]. Indeed, we observed fluid 
flow induced expression and nuclear accumulation of Snail, 
as well as increased vimentin and reduced E-cadherin 
expression. Interestingly, while Snail and the highly homol-
ogous protein Slug are frequently co-expressed [44], Snai2, 
the gene encoding Slug, is clearly down-regulated upon 
fluid flow. Therefore, we conclude that in this context Snail, 
but not Slug, is responsible for the expression of mesenchy-
mal markers and for repression of the epithelial E-cadherin 
gene.
In renal epithelial cells, TGF-β-induced expression of 
canonical SMAD2/3 targets and EMT markers is the con-
sequence of both SMAD2/3 and ERK1/2 activation, since 
upstream ALK4/5/7 and MEK1/2 inhibitors both reduce but 
not completely block the ligand-induced response (Fig. 6, 
Supplementary Material 1, Fig. S4). While the fluid flow-
induced response was largely blocked by the ALK4/5/7 
inhibitor, the MEK inhibitor, however, further enhanced 
expression of Pai1, Col1a1, Ptgs2, Snai1, and Vim, though 
Fn1 expression was less increased (Figs.  5, 6). It is well 
known that a cross-talk between the canonical (SMAD2/3) 
and the non-canonical (MAPK/ERK) TGF-β pathways take 
place at different levels and via direct or indirect pathways 
[70]. These data support a previous study describing antag-
onistic interactions between TGF-β1-mediated expression 
of fibrogenesis genes and the cAMP/PKA pathway. On 
the one hand, cAMP/PKA promoted TGF-β1 production 
and expression of target genes (including collagen-I and 
fibronectin) in MDCK cells and an embryonic kidney cyst 
model, being inhibited by an ALK5-inhibitor. On the other 
hand, upon addition of TGF-β1 to the culture medium of 
MDCK cells, fibronectin expression is negatively regu-
lated upon cAMP treatment, via ERK1/2 [71]. A direct 
link between TGF-β and MAPK/ERK signaling, is the 
phosphorylation of ShcA by the activated TGF-β receptor 
complex [52]. ShcA competes with SMAD2/3 for bind-
ing to the TGF-β receptor, and stabilizes the TGF-β recep-
tor complexes in caveolae, where it activates MAPK/ERK 
signaling [72]. Consequently, reduced ShcA expression 
results in increased levels of TGF-β receptor complexes in 
clathrin-coated pits, leading to enhanced SMAD2/3 acti-
vation. Alternatively, activated ERK1/2, by TGF-β/ALK5 
or by other growth factors, can mediate phosphorylation 
of the regulatory SMADs (R-SMAD) as well as phospho-
rylation of the SMAD2/3 linker region, which modulate 
transcriptional activity of the SMAD complex [53, 73]. 
Because the multiple interactions between the MAPK/ERK 
and the TGF-β signaling cascades, the integration of these 
pathways is biological context dependent and complex, and 
therefore difficult to predict .
Since Fn1 expression was significantly increased by 
TGF-β1 at a later time point than the other target genes 
(Fig.  2d); it is likely that besides SMAD2/3, other tran-
scription factors are involved in its mRNA expression. The 
literature indeed shows that Fn1 expression was dependent 
on Snail or Slug expression and other transcription factors 
[74, 75]. Furthermore, to induce Fn1 expression, it likely 
needs stabilized SMAD2/3 phosphorylation, which is 
achieved by ERK-mediated nuclear SMAD linker phospho-
rylation. This could be the explanation that TGF-β and fluid 
flow-induced Fn1 expression is largely blocked upon MEK 
inhibition as proposed in the model depicted in Fig. 7.
The Ptgs2 gene, encoding the COX2 protein, is widely 
used as a control for fluid flow. COX2-derived prostaglan-
dins have been shown to stimulate cell proliferation, fluid 
secretion, and cyst formation in vitro, probably via increas-
ing the cAMP levels. Furthermore, COX2-derived products 
show increased expression in animal models for PKD, and 
COX2 inhibitors showed minimal beneficial effect on PKD 
progression in rodent models [76, 77]. Our data show that 
Ptgs2 expression is also TGF-β dependent and is regulated 
via shear stress in PTECs.
In conclusion, we found fluid shear stress-induced 
SMAD2/3 activation and target gene expression in ciliated 
and non-ciliated PTECs, suggesting that cilia are not criti-
cally inducing the shear stress-induced SMAD2/3 response 
of renal epithelial cells. Overall, our data indicate a com-
plex response, in which yet unidentified mechano-sensors 
are involved. The response is dependent on autocrine 
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TGF-β/ALK5-mediated signaling, but not on activin/
ALK4. Under fluid shear stress conditions, the expres-
sion of most SMAD2/3 target genes is partially repressed 
by MAPK/ERK possibly via TGF-β/ALK5-mediated acti-
vation of MEK1/2 (Fig.  7) or via activation of this path-
way by other yet unidentified autocrine (growth) factors. 
In renal (cystic) disease, compensatory hyperfiltration 
and increased shear stress might contribute to induced 
SMAD2/3 activation, a well-known factor in the control of 
epithelial cell plasticity and fibrosis.
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